Paul Govern Archive — Page 24 of 54

March 11, 2021

Genotype looms large in risk for post-op arrhythmia

Postoperative atrial fibrillation (PoAF), a form of arrhythmia, complicates 20-40% of cardiac surgical procedures and 10–20% of non-cardiac thoracic operations, cropping up two to four days after surgery to pose risk of stroke, heart attack, mortality, longer hospital stays and greater cost.

March 4, 2021

COVID-19 survey data added to All of Us platform

In December 2020, the federal government’s massive precision medicine research initiative, All of Us (AoU), made available to qualified researchers initial results from its ongoing COVID-19 Participant Experience (COPE) Survey, as well as physical activity and heart rate data collected from Fitbit devices worn by AoU participants.

Officials cut the ribbon to celebrate the opening of Carefluent Connect, VUMC’s new durable medical equipment company located at Vanderbilt Health One Hundred Oaks.
March 3, 2021

VUMC launches new medical equipment company Carefluent Connect

After two years of planning and regulatory approvals, Vanderbilt University Medical Center is preparing to launch a durable medical equipment (DME) company, Carefluent Connect, LLC.

March 3, 2021

REDCap Day highlights new features, innovative use cases

Each year at VUMC, REDCap Day brings together local users from VUMC, Vanderbilt University and Meharry Medical College for a morning of brief presentations on innovative use cases and new and upcoming features.

February 25, 2021

Epic founder Faulkner highlights DBMI online seminar

The CEO and founder of one of the world’s largest electronic health record (EHR) vendors, Judith Faulkner of Epic Systems Corp., spoke about her company and answered questions recently at the Department of Biomedical Informatics weekly online seminar.

February 11, 2021

Data mart speeds recruitment for COVID research

The arrival last March of the COVID-19 pandemic in Tennessee presented challenges for the clinical research enterprise at Vanderbilt University Medical Center. Prompt recruitment of patients newly diagnosed with COVID-19 into clinical trials was, and remains, a public health imperative with top-level backing from the federal government.